DAFTAR PUSTAKA

1. Remington JS. McLeod Rima. Wilson CB, et al. Toxoplasmosis. In: Remington JS.
Klein JO. Wilson CB, et al. Infectious Diseases of the Fetus and Newborn Infant. 7th ed.
Philadelphia: Elsevier Saunders, 2011: 918-1041
2. Munoz-Roldan Melba. Heimesaat Markus M. Liesenfeld Oliver. Toxoplasmosis. In:
Jeremy Farrar. Hotez Peter J. Junghanss Thomas. Mansons Tropical Diseases. 23 rd ed.
Texas: Elsevier Sauders, 2014: 652-63
3. Boyer Kenneth M. Marcinak John F. McLeod Rima L. Toxoplasmosis gondii
(Toxoplasmosis). In: Long Sarah S. Pickering Larry K. Prober Charles G. Principles
and Practice of Pediatric Infectious Diseases. 3 rd ed. New York: Churchill Livingstone,
2008:1267-88
4. Romand Stephane. Wallon Martine. Franck Jacqueline. Prenatal Diagnosis Using
Polymerase Chain Reaction on Amniotic Fluid for Congenital Toxoplasmosis. The
American College of Obstet and Gynecol 2001; 97: 296-300
5. McAuley. Boyer Kenneth M. Remington Jack S, et al: Toxoplasmosis. In: Cheryy
James D. Harrison Gail J. Kaplan Sheldon L. Feigin and Cherrrys Textbook of
Pediatric Infectious Disesases. 7th ed. Texas: Elsevier Saunders, 2014: 2986-3004
6. Brooks GF. Butel JS. Ornston LN, et al. Medical Microbiology. 19th ed. London:
Appleton & Lange, 1991
7. Gomella TL. Cunnungham MD. Eyal FG. Neonatology Management, Procedurs, On-
Call Problem, Diseases, and Drugs. New York: Mc Graw Hill Education, 2013.
8. Tamma Pranita. Toxoplasmosis. Pediatrics in Review 2007; 28: 470-471.
9. McLeod Rima. Remington Jack S. Toxoplasmosis. In: Behrman. Kliegman. Arvin.
Nelson Ilmu Kesehatan Anak. 15th ed. Vol. 2 Jakarta: EGC 1999, 1204-1213
10. Soedarmo SSP. Garna Herry. Hadinegoro Sri Rexeki S, et al. Buku Ajar Infeksi dan
Pediatri Tropis. 2nd ed. Jakarta: Badan Penerbit IDAI, 2013
11. Chaparro Aida. Mitchell Charles D. Toxoplasma gondii. In: Hutto Cecelia. Congenital
and Peronatal Infections A Concise Guide to Diagnosis. New Jersy: Humana Press Inc.,
2006: 245-260
12. Baratawidjadja Karnen G. Imunologi Dasar. 3rd ed. Jakarta: Penerbit FK UI, 1996.
13. Isaacs David. Evidence-Based Neonatal Infections. West Sussex, UK: BMJ Publishing
Group Ltd., 2014
14. Munaf Sjamsuir. Catatan Kuliah Farmakologi. Jakarta: Penerbit Buku Kedokteran
EGC, 1994
15. Machado Anderson S. Andrade Glaucia. Januario Jose N, et al. IgG and IgM Western
Blot Assay For Diagnosis of Congenital Toxoplasmosis. Mern Inst Oswaldo 2010; 105:
757-761
16. GF Chen. YH Fang. DX Guo, et al. Follow Up 16 Cases with Congenital

1
 Toxoplasmosis Treated with Azitromycin. Zhonghua Er Ke Za Zhi 2004; 1: 23-25.
Abstract.
17. Tabbara Khalid F. Disruption of the Choroidoretinal Interface by Toxoplasma. Eye
1990; 4: 366-373.
18. Gaddi Pamela J. Yap George S. Cytokine Regulation of Immunopathology in
Toxoplasmosis. Immunology and Cell Biology 2007; 85: 155-159
19. Levene Malcolm. Tudehope David L. Sinha Sunil. Essential Neonatal Medicine. 4th ed.
Massachusetss: Blackwell Publishing, 2008
20. Lebech M. Joynson DHM. Seitz HM, et al. Classification System and Case
Deefinitions of Toxoplasma gondii Infection in Immocompetent Pregnant Women and
Their Congenitally Infected Offspring. Eur. J. Clin. Mikrobiol. Infect. Dis. 1996; 15:
799-805
21. Correa D. Canedo-Solares I. Ortiz-Alegria B. et al: Congenital and Acquired
Toxoplasmosis: diversity and role of antibodies in different compatements of the host.
Parasite Immonology 2007; 29: 651-660.
22. Kosim MS. Yunanto Ari. Dewi Rizalya, et al. Buku Ajar Neonatologi. 1st ed. Jakarta:
Badan Penerbit IDAI, 2012.
23. Serranti D. Buonsenso D. Valentini P. Congenital Toxoplasmosis Treatment.European
Review for Medical Pharmacological Sciences 2011; 15: 193-198
24. Red Book 2006 Report of The Committee On Infectious Diseases. Toxoplasmosis
gondii. Elk Grove Village, Il: Committee on Infectious Diseases American Academy of
Pediatrics, 2006
25. Cederqvist LARS L. Kimball Anne C. Ewool Linda C, et al. Fetal Immune Response
Following Congenital Toxoplasmosis. Cornell Medical Center Obstetrics and
Gynecology 1977; 50: 200-204
26. Guerina Nicholas G. Hsu Ho-Wen. Meissner Cody, et al. Neonatal Serologic Screening
and Early Treatment fo Congenital Toxoplasma Gondii Infection. The New England
Journal of Medicine 1994;330: 1858-1863
27. Jones Jeffry l. Lpez Adriana. Wilson Marianna, et al. Congenital Toxoplasmosis: A
Review. CME Review Article 2001; 56: 296-303.
28. Queroz de Andrade Glaucia. Macedo de Resande Luciana. Goulart Eugino Marcos
Andrade, et al. Hearing Loss in Congenital Toxoplasmosis detected by newborn
Screening. Brazillian Journal of Otorhinolaryngocology 2008; 74(1): 21-28.
29. Remington JS. Miller MJ. Brownlee I. IgM Antibodies in Acute Toxoplasmosis: I.
Diagnostic Significance in Congenital Cases and A Method for Their Rapid
Demonstration. Pediatrics 1968; 41: 1082-1091
30. Katzung Bertram G. Farmakologi Dasar dan Klinik. 6 th ed. Jakarta: Penerbit Buku
Kedokteran EGC, 1995.
31. Guerian NG. Lee Jennifer. Lynfield Ruth. Congenital Toxoplasmosis: Treatment,

2
 Outcome, and Prevention. Uptodate 2012; 1-9
32. C Silveira. R Belfort. C Muccioli, et al. The Effect of Long-Term intermittent
Trimethroprim/Sulfamethoxazole Treatment on Reccurences of Toxoplasmic
Retinochoroiditis. Am. J Opthalmol 2002; 134(1): 41-6
33. JP Feix. Lira RP. Zacchia RS, et al. Trimethoprim Sulfamethoxazole versus Placebo to
Reduce The Risk of Recurrences of Toxoplasma gondii Retinochoroiditis: Randomized
Controlled Clinical Trial. Am J. Ophthalmol 2014; 157(4): 762-766.e1.
34. Bosch-Driessen EH. Rothova A. Sense and Nonsense of Corticosteroid Administration
in The Treatment of Ocular Toxoplasmosis. Br J Ophthalmol 1998; 82: 858-860
35. S Jasper. SS Vedula. SS John, et al. Corticosteroid as Adjuvant Therapy fo Ocular
Toxoplasmosis (Review). The Cochrane Collaboration 2013; 4: 1-8
36. Wallon Martine. Kodjikian Laurent. Binquet Christine, et al. Long Term Ocular
Prognosis in 327 Children with Congenital Toxoplasmosis. Pediatrics 2004; 113: 1567-
1572
37. Melamed J. Eckert GU. Spadoni VS. et al. Ocular Manifestations of Congenital
Toxoplasmosis. Eye 2010; 24: 528-534
38. Lipka Bozena. Milewska-Bobula Bgumila. Filipek Marian. Monitoring of Plasma
Concentration of Pyrimethamine (PYR) in Infants with Congeenital Toxoplasma
Gondii Infection Own Observations. Wiadomosci Parazytologiczne 2011; 57(2): 87-
92
39. Wallon Martine. Gaweg Justus G. Abrahamowicz Michal, et al. Ophthalmic Outcomes
of Congenital Toxoplasmosis Followed Untill Adolescene. Pediatrics 2014; 133:e601-
608
40. McLeod Rima, Boyer Keneth, Karrison Theodore, et al: Outcome of Treatment for
Congenital Toxoplasmosis, 1981-2004: The National Collaborative Chicago-Based,
Congenital Toxoplasmosis Study. J. Clin Infect Dis. 2006; 42:1383-1394.
41. Franco PS. Gomes AO. Barbosa BF. Et al. Azithromycin and spiramycin induce anti-
inflamatory response in human trophoblastic (BeWo) cells infected by Toxoplasma
gondii but are able to control infection. Placenta 2011; 32: 838-844
42. Villena I. Aubert D. Leroux B, et al. Pyrimethamine-Sulfadoxine Treatment of
Congenital Toxoplasmosis: Follow-up of 78 Cases Between 1980 and 1997. Reims
Toxoplasmosis Group 1998; 30(3): 25-300.